Additionally, subcutaneous injection of hematopoietic growth factors such as stem cell factor and granulocyte colony-stimulating factor led to a reduction in Aβ plaques and increase in microglial markers Iba1 and CD68 around Aβ plaques in the APP/PS1 AD mouse model (30). This evidence concerns the gene APP and Alzheimer disease.